Cargando…
Multigene prognostic tests in breast cancer: past, present, future
There is growing consensus that multigene prognostic tests provide useful complementary information to tumor size and grade in estrogen receptor (ER)-positive breast cancers. The tests primarily rely on quantification of ER and proliferation-related genes and combine these into multivariate predicti...
Autores principales: | Győrffy, Balázs, Hatzis, Christos, Sanft, Tara, Hofstatter, Erin, Aktas, Bilge, Pusztai, Lajos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307898/ https://www.ncbi.nlm.nih.gov/pubmed/25848861 http://dx.doi.org/10.1186/s13058-015-0514-2 |
Ejemplares similares
-
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer
por: Sanft, Tara, et al.
Publicado: (2015) -
Uptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer
por: Aktas, Bilge, et al.
Publicado: (2016) -
A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients
por: Pongor, Lőrinc, et al.
Publicado: (2015) -
An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes
por: Győrffy, Balázs, et al.
Publicado: (2018) -
Mutation based treatment recommendations from next generation sequencing data: a comparison of web tools
por: Patel, Jaymin M., et al.
Publicado: (2016)